Decout et al. (2021) provides a comprehensive review of therapeutic compounds targeting the cGAS-STING pathway that potentially could be beneficial for neurodegenerative diseases characterized with overactive STING signaling (Decout et al., 2021). Here, STING1 is linked to neurodegenerative disease.